Literature DB >> 8486712

Structural and functional analyses of the Arg-Gly-Asp sequence introduced into human lysozyme.

T Yamada1, M Matsushima, K Inaka, T Ohkubo, A Uyeda, T Maeda, K Titani, K Sekiguchi, M Kikuchi.   

Abstract

To determine the functional conformation of the Arg-Gly-Asp (RGD) sequence, we have constructed mutant proteins by inserting 4-12 amino acid residues from the RGD region of human fibronectin between Val74 and Asn75 of human lysozyme. RGDS-, GRGDSP-, TGRGDSPA-, VTGRGDSPAS-, and AVTGRGDS-PASS-introduced mutant lysozymes were expressed in yeast, purified, and designated as RGD4, -6, -8, -10, and -12, respectively. Using baby hamster kidney cells, RGD8, RGD10, and RGD12 were shown to possess high cell adhesion activity nearly equal to 10% of human vitronectin activity. RGD4 and RGD6 exhibited somewhat lower cell adhesion activity. The activities of these mutant proteins were inhibited by the addition of either GRGDSP peptide or polyclonal antibody against vitronectin receptor, as was the case for the vitronectin activity. The results suggest that the cell adhesion signals are transduced to cells through the interaction with the vitronectin receptor. The three-dimensional structures of RGD4 and RGD8 were determined at 1.8-A resolution by x-ray crystallography. A model of the inserted region in RGD4 could be built in the electron density map, but the positions of the preceding residues, Ala73-Val74, were uncertain. The inserted region in RGD8 did not demonstrate continuous electron densities. The results suggest that these RGD sequence-containing regions are highly flexible and that such flexibility could allow the conformation of the RGD regions to be induced to fit into the binding pocket of the integrin receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486712

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.

Authors:  G Proimos
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

3.  Proteolytic excision and in situ cyclization of a bioactive loop from an REI-VL presentation scaffold.

Authors:  L R Helms; R Wetzel
Journal:  Protein Sci       Date:  1994-07       Impact factor: 6.725

4.  Scorpion toxins as natural scaffolds for protein engineering.

Authors:  C Vita; C Roumestand; F Toma; A Ménez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

5.  Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.

Authors:  Richard H Kimura; Aron M Levin; Frank V Cochran; Jennifer R Cochran
Journal:  Proteins       Date:  2009-11-01

6.  Development of peptide-functionalized synthetic hydrogel microarrays for stem cell and tissue engineering applications.

Authors:  Jia Jia; Robert C Coyle; Dylan J Richards; Christopher Lloyd Berry; Ryan Walker Barrs; Joshua Biggs; C James Chou; Thomas C Trusk; Ying Mei
Journal:  Acta Biomater       Date:  2016-09-07       Impact factor: 8.947

7.  Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities.

Authors:  Adam P Silverman; Aron M Levin; Jennifer L Lahti; Jennifer R Cochran
Journal:  J Mol Biol       Date:  2008-11-12       Impact factor: 5.469

8.  Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen gamma chain obtained by carrier protein-driven crystallization.

Authors:  J P Donahue; H Patel; W F Anderson; J Hawiger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.